Does Rallies show Form 4 insider transactions for INDV?

Yes. Rallies tracks INDV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is INDV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for INDV. It does not provide personalized investment advice.

INDV (Indivior Pharmaceuticals, Inc. Common Stock) Stock Analysis - Insider Trades

Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of May 20, 2026, INDV trades at $38.04 with a market cap of $4.32B and a P/E ratio of 22.16. INDV moved +2.91% today. Year to date, INDV is +3.53%; over the trailing twelve months it is +216.69%. Its 52-week range spans $7.33 to $41.00. Analyst consensus is strong buy with an average price target of $50.67. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading INDV stock inside the company?

Recent INDV insider activity includes Ryan Barbara bought 8, Ryan Barbara bought 31, Kingsley Stuart A bought 940, Ryan Barbara bought 775, and Humphreys Keith bought 775. Rallies tracks insider transaction dates, shares, prices, and estimated values.

INDV Key Metrics

Key financial metrics for INDV
Metric	Value
Price	$38.04
Market Cap	$4.32B
P/E Ratio	22.16
EPS	$1.68
Dividend Yield	0.00%
52-Week High	$41.00
52-Week Low	$7.33
Volume	1.02M
Avg Volume	0
Revenue (TTM)	$1.24B
Net Income	$210.00M
Gross Margin	80.23%

Recent INDV Insider Trades

Ryan Barbara bought 8 (~$248.68) on Mar 13, 2026.
Ryan Barbara bought 31 (~$1.01K) on Mar 9, 2026.
Kingsley Stuart A bought 940 (~$29.95K) on Mar 6, 2026.
Ryan Barbara bought 775 (~$27.43K) on Jan 5, 2026.
Humphreys Keith bought 775 (~$27.43K) on Jan 5, 2026.

Latest INDV News

Monthly Injectable Buprenorphine Linked to 3.5–8.1x Lower Relapse Risk and 62% Fewer Infections — May 20, 2026
Indivior launches $175M accelerated share repurchase, initial 3.7M shares delivered — May 4, 2026
Indivior Q1 Revenue Jumps 19%, SUBLOCADE Sales Climb 32%, Raises 2026 Guidance — Apr 30, 2026
Indivior Model Projects 747 Staff Hour Cuts and $22,148 Monthly Savings in Prisons — Mar 31, 2026
Indivior Prices $450M 0.625% Convertible Notes to Repay Debt, Buy Shares — Mar 13, 2026

INDV Analyst Consensus

4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.67.

Common questions about INDV

Who is trading INDV stock inside the company?: Recent INDV insider activity includes Ryan Barbara bought 8, Ryan Barbara bought 31, Kingsley Stuart A bought 940, Ryan Barbara bought 775, and Humphreys Keith bought 775. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for INDV?: Yes. Rallies tracks INDV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is INDV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for INDV. It does not provide personalized investment advice.